Advertisement
Research ArticleDrug Discovery and Translational Medicine

Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates

Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleDrug Discovery and Translational Medicine

Selectivity of BI 689648, FAD286, and LCI699 in NHPs

Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
Journal of Pharmacology and Experimental Therapeutics October 1, 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement